Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Extinction learning is an important mechanism in the successful psychological treatment of anxiety. Individual differences in response and relapse following Cognitive Behavior Therapy may in part be explained by variability in the ease with which fears are extinguished or the vulnerability of these fears to re-emerge. Given the role of the endocannabinoid system in fear extinction, this study investigates whether genetic variation in the endocannabinoid system explains individual differences in response to CBT. Children (N = 1,309) with a primary anxiety disorder diagnosis were recruited. We investigated the relationship between variation in the CNR1, CNR2, and FAAH genes and change in primary anxiety disorder severity between pre- and post-treatment and during the follow-up period in the full sample and a subset with fear-based anxiety disorder diagnoses. Change in symptom severity during active treatment was nominally associated (P 

Original publication




Journal article


Am J Med Genet B Neuropsychiatr Genet

Publication Date





144 - 155


Cognitive Behavior Therapy, anxiety, children, endocannabinoids, fear extinction, Adolescent, Amidohydrolases, Anxiety, Anxiety Disorders, Child, Cognitive Behavioral Therapy, Endocannabinoids, Fear, Female, Genetic Variation, Humans, Male, Polymorphism, Single Nucleotide, Receptor, Cannabinoid, CB1, Receptor, Cannabinoid, CB2, Treatment Outcome